Estrogens and atherosclerosis: Insights from animal models and cell systems

Journal of Molecular Endocrinology

Volumn 48, Issue 2, 2012, Pages 13-29

  Nofer, Jerzy Roch ^a,b  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^b UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

2 HYDROXYESTRADIOL; ANDROGEN RECEPTOR; ANDROSTANOLONE; APOLIPOPROTEIN E; AROMATASE; CATECHOL METHYLTRANSFERASE; CD40 ANTIGEN; CD40 LIGAND; CYTOCHROME P450; ENDOTHELIAL NITRIC OXIDE SYNTHASE; EPIMESTROL; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; ESTRONE; G PROTEIN COUPLED RECEPTOR 30; GESTAGEN; HIGH DENSITY LIPOPROTEIN; INTERCELLULAR ADHESION MOLECULE 1; LOW DENSITY LIPOPROTEIN RECEPTOR; PADGEM PROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; PHYTOESTROGEN; PRASTERONE; PROSTAGLANDIN SYNTHASE; PROTEIN KINASE B; TESTOSTERONE; UNINDEXED DRUG; VASCULAR CELL ADHESION MOLECULE 1;

ANTIINFLAMMATORY ACTIVITY; ARTERY WALL; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; B LYMPHOCYTE; BIOAVAILABILITY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CAROTID ARTERY; CELL PROLIFERATION; CELL SURVIVAL; CELL TYPE; CHOLESTEROL INTAKE; CHOLESTEROL TRANSPORT; CYTOKINE PRODUCTION; DENDRITIC CELL; DIABETES MELLITUS; DISEASE SEVERITY; DYSLIPIDEMIA; ENDOPLASMIC RETICULUM; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; ENZYME PHOSPHORYLATION; ESTROGEN BLOOD LEVEL; ESTROGEN SYNTHESIS; EXPERIMENTAL RABBIT; GENETIC ENGINEERING; HEART INFARCTION; HEART PROTECTION; HORMONAL THERAPY; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; IN VIVO STUDY; INCIDENCE; MACROPHAGE; MAST CELL; MONOCYTE; MONONUCLEAR CELL; MYOFIBROBLAST; NONHUMAN; OVARIECTOMY; POSTMENOPAUSE; PRIORITY JOURNAL; REVIEW; RISK REDUCTION; SMOOTH MUSCLE FIBER; T LYMPHOCYTE; TRANSGENIC MOUSE; VASODILATATION;

ANIMALS; ATHEROSCLEROSIS; CHOLESTEROL, DIETARY; DENDRITIC CELLS; DISEASE MODELS, ANIMAL; ENDOTHELIAL CELLS; ESTROGENS; HUMANS; LYMPHOCYTES; MACROPHAGES; MICE; MICE, TRANSGENIC; MYOCYTES, SMOOTH MUSCLE; RECEPTORS, ESTROGEN;

EID: 84858849361     PISSN: 09525041     EISSN: 14796813     Source Type: Journal    
DOI: 10.1530/JME-11-0145     Document Type: Review

References (199)

1. Aavik E, du Toit D, Myburgh E, Frosen J & Hayry P 2001 Estrogen receptor b dominates in baboon carotid after endothelial denudation injury. Molecular and Cellular Endocrinology 182 91-98. (doi:10.1016/S0303-7207(01)00552-4)
2. Adams MR, Golden DL, Anthony MS, Register TC & Williams JK 2002a The inhibitory effect of soy protein isolate on atherosclerosis in mice does not require the presence of LDL receptors or alteration of plasma lipoproteins. Journal of Nutrition 132 43-49.
3. Adams MR, Golden DL, Register TC, Anthony MS, Hodgin JB, Maeda N & Williams JK 2002b The atheroprotective effect of dietary soy isoflavones in apolipoprotein EK/K mice requires the presence of estrogen receptor-a. Arteriosclerosis, Thrombosis, and Vascular Biology 22 1859-1864. (doi:10.1161/01.ATV.0000042202.42136.D0)
4. Adamski J, Ma Z, Nozell S & Benveniste EN 2004 17b-Estradiol inhibits class II major histocompatibility complex (MHC) expression: influence on histone modifications and cbp recruitment to the class II MHC promoter. Molecular Endocrinology 18 1963-1974. (doi:10.1210/me.2004-0098)
5. Akarasereenont P, Techatraisak K, Thaworn A & Chotewuttakorn S 2000 The induction of cyclooxygenase-2 by 17b-estradiol in endothelial cells is mediated through protein kinase C. Inflammation Research 49 460-465. (doi:10.1007/s000110050617)
6. Allred KF, Smart EJ & Wilson ME 2006 Estrogen receptor-a mediates gender differences in atherosclerosis induced by HIV protease inhibitors. Journal of Biological Chemistry 281 1419-1425. (doi:10.1074/jbc.M506046200)
7. Alvarez RJ, Gips SJ, Moldovan N, Wilhide CC, Milliken EE, Hoang AT, Hruban RH, Silverman HS, Dang CV & Goldschmidt-Clermont PJ 199717b-Estradiol inhibits apoptosis of endothelial cells. Biochemical and Biophysical Research Communications 237 372-381. (doi:10.1006/bbrc.1997.7085)
8. Alvarez A, Hermenegildo C, Issekutz AC, Esplugues JV & Sanz MJ 2002 Estrogens inhibit angiotensin II-induced leukocyte-endothelial cell interactions in vivo via rapid endothelial nitric oxide synthase and cyclooxygenase activation. Circulation Research 91 1142-1150.(doi:10.1161/01.RES.0000046018.23605.3E)
9. Arnal JF, Fontaine C, Billon-Galés A, Favre J, Laurell H, Lenfant F & Gourdy P 2010 Estrogens receptors and endothelium. Arteriosclerosis, Thrombosis, and Vascular Biology 30 1506-1512. (doi:10.1161/ATVBAHA.109.191221)
10. Badeau RM, Metso J, Tikkanen MJ & Jauhiainen M 2007a High density lipoprotein-associated 17b-estradiol fatty acyl ester uptake by Fu5AH hepatoma cells: implications of the roles of scavenger receptor class B, type I and the low-density lipoprotein receptor. Biochimica et Biophysica Acta 1171 1329-1344.
11. Badeau RM, Vihma V, Mikkola TS, Tittinen A & Tikkanen MJ 2007b Estradiol fatty acid esters in adipose tissue and serum of pregnant and pre- and postmenopausal women. Journal of Clinical Endocrinology and Metabolism 92 4327-4331. (doi:10.1210/jc.2007-1372)
12. Badeau RM, Metso J, Wähälä K, Tikkanen MJ & Jauhiainen M 2009 Human macrophage cholesterol efflux potential is enhanced by HDL-associated 17b-estradiol fatty acyl esters. Journal of Steroid Biochemistry and Molecular Biology 116 44-49. (doi:10.1016/j.jsbmb.2009.04.008)
13. Barchiesi F, Jackson EK, Fingerle J, Gillespie DG, Odermatt B & Dubey RK 2006 2-Methoxyestradiol, an estradiol metabolite, inhibits neointima formation and smooth muscle cell growth via double blocade of the cell cycle. Circulation Research 99 266-274. (doi:10.1161/01.RES.0000233318.85181.2e)
14. Bellosta S, Baetta R, Canavesi M, Comparato C, Granata A, Monetti M, Cairoli F, Eberini I, Puglisi L & Corsini A 2007 Raloxifene inhibits matrix metalloproteinases expression and activity in macrophages and smooth muscle cells. Pharmacological Research 56 160-167.(doi:10.1016/j.phrs.2007.05.004)
15. Billon-Galés A, Fontaine C, Douin-Echinard V, Delpy L, Berges H, Calippe B, Lenfant F, Laurell H, Guéry JC, Gourdy P et al. 2009a Endothelial estrogen receptor-a plays a crucial role in the atheroprotective action of 17b-estradiol in low-density lipoprotein receptor-deficient mice. Circulation 120 2567-2576. (doi:10.1161/CIRCULATIONAHA.109.898445)
16. Billon-Galés A, Fontaine C, Filipe C, Douin-Echinard V, Fouque MJ, Flouriot G, Gourdy P, Lenfant F, Laurell H, Krust A et al. 2009b The transactivating function 1 of estrogen receptor a is dispensable for the vasculoprotective actions of 17b-estradiol. PNAS 106 2053-2058. (doi:10.1073/pnas.0808742106)
17. Billon-Galés A, Krust A, Fontaine C, Abot A, Flouriot G, Toutain C, Berges H, Gadeau AP, Lenfant F, Gourdy P et al. 2011 Activation function 2 (AF2) of estrogen receptor-a is required for the atheroprotective action of estradiol but not to accelerate endothelial healing. PNAS 108 13311-13316. (doi:10.1073/pnas.1105632108)
18. Bolego C, Rossoni G, Fadini GP, Vegeto E, Pinna C, Albiero M, Boscaro E, Agostini C, Avogaro A, Galon RM et al. 2010 Selective estrogen receptor-a agonist provides widespread heart and vascular protection with enhanced endothelial progenitor cell mobilization in the absence of uterotrophic action. FASEB Journal 24 2262-2272. (doi:10.1096/fj.09-139220)
19. Bourassa PA, Milos PM, Gaynor BJ, Breslow JL & Aiello RJ 1996 Estrogen reduces atherosclerotic lesion development in apolipoprotein E-deficient mice. PNAS 93 10022-10027. (doi:10.1073/pnas.93.19.10022)
20. Bourghardt J, Bergstrom G, Krettek A, Sjoberg S, Borén J & Tivesten A 2007 The endogenous estradiol metabolite 2-methoxyestradiol reduces atherosclerotic lesion formation in female apolipoprotein E-deficient mice. Endocrinology 148 4128-4132. (doi:10.1210/en.2007-0259)
21. Bourghardt J, Wilhelmson AS, Alexanderson C, De Gendt K, Verhoeven G, Krettek A, Ohlsson C & Tivesten A 2010 Androgen receptor-dependent and independent atheroprotection by testosterone in male mice. Endocrinology 151 5428-5437. (doi:10.1210/en.2010-0663)
22. Broughton BR, Miller AA & Sobey CG 2010 Endotheliumdependent relaxation by G protein-coupled receptor 30 agonists in rat carotid arteries. American Journal of Physiology. Heart and Circulatory Physiology 298 H1055-H1061. (doi:10.1152/ajpheart.00878.2009)
23. Bruce-Keller AJ, Keeling JL, Keller JN, Huang FF, Camondola S & Mattson MP 2000 Antiinflammatory effects of estrogen on microglial activation. Endocrinology 141 3646-3656. (doi:10.1210/en.141.10.3646)
24. Burek M, Arias-Loza PA, Roewer N & Forster CY 2010 Claudin-5 as a novel estrogen target in vascular endothelium. Arteriosclerosis, Thrombosis, and Vascular Biology 30 298-304. (doi:10.1161/ATV-BAHA.109.197582)
25. Calippe B, Douin-Echinard V, Laffargue M, Laurell H, Rana-Poussine V, Pipy B, Guéry JC, Bayard F, Arnal JF & Gourdy P 2008 Chronic estradiol administration in vivo promotes the proinflammatory response of macrophages to TLR4 activation: involvement of the phosphatidylinositol 3-kinase pathway. Journal of Immunology 180 7980-7988.
26. Calippe B, Douin-Echinard V, Delpy L, Laffargue M, Lélu K, Krust A, Pipy B, Bayard F, Arnal JF, Guéry JC et al. 2010 17b-Estradiol promotes TLR4-triggered proinflammatory mediator production through direct estrogen receptor a signaling in macrophages in vivo. Journal of Immunology 185 1169-1176. (doi:10.4049/jimmunol.0902383)
27. Cann JA, Register TC, Adams MR, St Clair RW, Espeland MA & Williams JK 2008 Timing of estrogen replacement influences atherosclerosis progression and plaque leukocyte populations in ApoEK/K mice. Atherosclerosis 201 43-52. (doi:10.1016/j.athero-sclerosis.2008.01.018)
28. Carbajal JM & Schaeffer RC Jr 1998 H2O2 and genistein differentially modulate protein tyrosine phosphorylation, endothelial morphology, and monolayer barrier function. Biochemical and Biophysical Research Communications 249 461-466. (doi:10.1006/bbrc.1998.9172)
29. Carreras E, Turner S, Paharkova-Vatchkova V, Mao A, Dascher C & Kovats S 2008 Estradiol acts directly on bone marrow myeloid progenitors to differentially regulate GM-CSF or Flt3 ligandmediated dendritic cell differentiation. Journal of Immunology 180 727-738.
30. Carreras E, Turner S, Frank MB, Knowlton N, Osban J, Centola M, Park CG, Simmons A, Alberola-Ila J & Kovats S 2010 Estrogen receptor signaling promotes dendritic cell differentiation by increasing expression of the transcription factor IRF4. Blood 115 238-246. (doi:10.1182/blood-2009-08-236935)
31. Carruba G, D'Agostino P, Miele M, Calabrò M, Barbera C, Bella GD, Milano S, Ferlazzo V, Caruso R, Rosa ML et al. 2003 Estrogen regulates cytokine production and apoptosis in PMA-differentiated, macrophage-like U937 cells. Journal of Cellular Biochemistry 90 187-196. (doi:10.1002/jcb.10607)
32. Chen JR, Haley RL, Hidestrand M, Shankar K, Liu X, Lumpkin CK, Simpson PM, Badger T & Ronis MJ 2006 Estradiol protects against ethanol-induced bone loss by inhibiting up-regulation of receptor activator of nuclear factor-kappaB ligand in osteoblasts. Journal of Pharmacology and Experimental Therapeutics 319 1182-1190. (doi:10.1124/jpet.106.109454)
33. Cheng W, Lau OD & Abumrad NA 1999 Two antiatherogenic effects of progesterone on human macrophages; inhibition of cholesteryl ester synthesis and block of its enhancement by glucocorticoids. Journal of Clinical Endocrinology and Metabolism 84 265-271. (doi:10.1210/jc.84.1.265)
34. Chi OZ, Barsoum S, Wen Y, Liu X & Weiss HR 2004 17b-Estradiol prevents blood-brain barrier disruption induced by VEGF. Hormone and Metabolic Research 36 272-276. (doi:10.1055/s-2004-814478)
35. Chow RW, Handelsman DJ & Ng MK 2010 Minireview: rapid actions of sex steroids in the endothelium. Endocrinology 151 2411-2422. (doi:10.1210/en.2009-1456)
36. Clarke M & Bennett M 2006 The emerging role of vascular smooth muscle cell apoptosis in atherosclerosis and plaque stability. American Journal of Nephrology 26 531-535. (doi:10.1159/000097815)
37. Corcoran MP, Lichtenstein AH, Meydani M, Dillard A, Schaefer EJ & Lamon-Fava S 2011 The effect of 17b-estradiol on cholesterol content in human macrophages is influenced by the lipoprotein milieu. Journal of Molecular Endocrinology 47 109-117. (doi:10.1530/JME-10-0158)
38. Crisafulli C, Bruscoli S, Esposito E, Mazzon E, Di Paola R, Genovese T, Bramanti P, Migliorati G & Cuzzocrea S 2009 PPAR-a contributes to the anti-inflammatory activity of 17b-estradiol. Journal of Pharmacology and Experimental Therapeutics 331 796-807. (doi:10.1124/jpet.109.156646)
39. Dai-Do D, Espinosa E, Liu G, Rabelink TJ, Julmy F, Yang Z, Mahler F & Luscher TF 1996 17b-Estradiol inhibits proliferation and migration of human vascular smooth muscle cells: similar effects in cells from postmenopausal females and in males. Cardiovascular Research 32 980-985.
40. Delarue F, Daunes S, Elhage R, Garcia A, Bayard F & Faye J 1998 Estrogens modulate bovine vascular endothelial cell permeability and HSP25 expression concomitantly. American Journal of Physiology. Heart and Circulatory Physiology 275 H1011-H1015.
41. Delpy L, Douin-Echinard V, Garidou L, Bruand C, Saoudi A & Guéry JC 2005 Estrogen enhances susceptibility to experimental autoimmune myasthenia gravis by promoting type 1-polarized immune responses. Journal of Immunology 175 5050-5057.
42. Deshpande R, Khalili H, Pergolizzi RG, Michael SD & Chang MD 1997 Estradiol down-regulates LPS-induced cytokine production and NFkB activation in murine macrophages. American Journal of Reproductive Immunology 38 46-54. (doi:10.1111/j.1600-0897.1997.tb00275.x)
43. Ding Q, Gros R, Limbird LE, Chorazyczewski J & Feldman RD 2009 Estradiol-mediated ERK phosphorylation and apoptosis in vascular smooth muscle cells requires GPR30. American Journal of Physiology. Cellular Physiology 297 C1178-C1187. (doi:10.1152/ajpcell.00185.2009)
44. Doran AC, Meller N & McNamara CA 2008 Role of smooth muscle cells in the initiation and early progression of atherosclerosis. Arteriosclerosis, Thrombosis, and Vascular Biology 28 812-819. (doi:10.1161/ATVBAHA.107.159327)
45. Douin-Echinard V, Laffont S, Seillet C, Delpy L, Krust A, Chambon P, Gourdy P, Arnal JF & Guéry JC 2008 Estrogen receptor a, but not beta, is required for optimal dendritic cell differentiation and CD40-induced cytokine production. Journal of Immunology 180 3661-3669.
46. Dubey RK & Jackson EK 2009 Potential vascular actions of 2-methoxyestradiol. Trends in Endocrinology and Metabolism 20 374-379. (doi:10.1016/j.tem.2009.04.007)
47. Egan KM, Lawson JA, Fries S, Koller B, Rader DJ, Smyth EM & Fitzgerald GA 2004 COX-2-derived prostacyclin confers atheroprotection on female mice. Science 306 1954-1957. (doi:10.1126/ science.1103333)
48. Elhage R, Arnal JF, Pieraggi MT, Duverger N, Fiévet C, Faye JC & Bayard F 1997a 17b-Estradiol prevents fatty streak formation in apolipoprotein E-deficient mice. Arteriosclerosis, Thrombosis, and Vascular Biology 17 2679-2684. (doi:10.1161/01.ATV.17.11.2679)
49. Elhage R, Bayard F, Richard V, Holvoet P, Duverger N, Fiévet C & Arnal JF 1997b Prevention of fatty streak formation of 17b-estradiol is not mediated by the production of nitric oxide in apolipoprotein E-deficient mice. Circulation 96 3048-3052.
50. Elhage R, Clamens S, Besnard S, Mallat Z, Tedgui A, Arnal J, Maret A & Bayard F 2001 Involvement of interleukin-6 in atherosclerosis but not in the prevention of fatty streak formation by 17b-estradiol in apolipoprotein E-deficient mice. Atherosclerosis 156 315-320. (doi:10.1016/S0021-9150(00)00682-1)
51. Esaki T, Hayashi T, Muto E, Kano H, Kumar TN, Asai Y, Sumi D & Iguchi A 2000 Expression of inducible nitric oxide synthase and Fas/Fas ligand correlates with the incidence of apoptotic cell death in atheromatous plaques of human coronary arteries. Nitric Oxide 4 561-571. (doi:10.1006/niox.2000.0311)
52. Espinosa E, Oemar BS & Luscher TF 1996 17b-Estradiol and smooth muscle cell proliferation in aortic cells of male and female rats. Biochemical and Biophysical Research Communications 221 8-14. (doi:10.1006/bbrc.1996.0535)
53. Fenoy FJ, Hernandez ME, Hernandez M, Quesada T, Salom MG & Hernandez I 2010 Acute effects of 2-methoxyestradiol on endothelial aortic NO release in male and ovarectomized female rats. Nitric Oxide 23 12-19. (doi:10.1016/j.niox.2010.03.002)
54. Florian M & Magder S 2008 Estrogen decreases TNF-a and oxidized LDL induced apoptosis in endothelial cells. Steroids 73 47-58. (doi:10.1016/j.steroids.2007.08.010)
55. Frazier-Jessen MR & Kovacs EJ 1995 Estrogen modulation of JE/monocyte chemoattractant protein-1 mRNA expression in murine macrophages. Journal of Immunology 154 1838-1845.
56. Freudenberger T, Oppermann M, Heim HK, Mayer P, Kojda G, Schror K & Fischer JW 2010 Proatherogenic effects of estradiol in a model of accelerated atherosclerosis in ovariectomized ApoE- deficient mice. Basic Research in Cardiology 105 479-486.(doi:10.1007/s00395-010-0091-6)
57. Friedrich EB, Clever YP, Wassmann S, Hess C & Nickenig G 2006 17b-Estradiol inhibits monocyte adhesion via down-regulation of Rac1 GTPase. Journal of Molecular and Cellular Cardiology 40 87-95. (doi:10.1016/j.yjmcc.2005.10.007)
58. Fujimoto J, Sakaguchi H, Hirose R & Tamaya T 1998 Sex steroidal regulation of vessel permeability associated with vessel endothelial cadherin (V-cadherin). Journal of Steroid Biochemistry and Molecular Biology 67 25-32. (doi:10.1016/S0960-0760(98)00069-7)
59. García Palacios V, Robinson LJ, Borysenko CW, Lehmann T, Kalla SE & Blair HC 2005 Negative regulation of RANKL-induced osteoclastic differentiation in RAW264.7 cells by estrogen and phytoestrogens. Journal of Biological Chemistry 280 13720-13727. (doi:10.1074/jbc.M410995200)
60. Gardner G, Banka CL, Roberts KA, Mullick AE & Rutledge JC 1999 Modified LDL-mediated increases in endothelial layer permeability are attenuated with 17b-estradiol. Arteriosclerosis, Thrombosis, and Vascular Biology 19 854-861. (doi:10.1161/01.ATV.19.4.854)
61. Geraldes P, Sirois MG, Bernatchez PN & Tanguay JF 2002 Estrogen regulation of endothelial and smooth muscle cell migration and proliferation: role of p38 and p42/44 mitogen-activated protein kinase. Arteriosclerosis, Thrombosis, and Vascular Biology 22 1585-1590. (doi:10.1161/01.ATV.0000035393.11854.6A)
62. Geraldes P, Sirois MG & Tanguay JF 2003 Specific contribution of estrogen receptors on mitogen-activated protein kinase pathways and vascular cell activation. Circulation Research 93 399-405. (doi:10.1161/01.RES.0000088640.18462.42)
63. Geraldes P, Gagnon S, Hadjadj S, Merhi Y, Sirois MG, Cloutier I & Tanguay JF 2006 Estradiol blocks the induction of CD40 and CD40L expression on endothelial cells and prevents neutrophil adhesion: an ERa-mediated pathway. Cardiovascular Research 71 566-573. (doi:10.1016/j.cardiores.2006.05.015)
64. Ghanam K, Lavagna C, Burgaud JL, Javellaud J, Ea-Kim L & Oudart N 2000 Involvement of cyclooxygenase 2 in the protective effect of 17b-estradiol on hypercholesterolemic rabbit aorta. Biochemical and Biophysical Research Communications 275 696-703. (doi:10.1006/bbrc.2000.3278)
65. Ghisletti S, Meda C, Maggi A & Vegeto E 2005 17b-Estradiol inhibits inflammatory gene expression by controlling NF-kB intracellular localization. Molecular and Cellular Biology 25 2957-2968. (doi:10. 1128/MCB.25.8.2957-2968.2005)
66. Gibson LL, Hahner L, Osborne-Lawrence S, German Z, Wu KK, Chambliss KL & Shaul PW 2005 Molecular basis of estrogeninduced cyclooxygenase type 1 upregulation in endothelial cells. Circulation Research 96 518-525. (doi:10.1161/01.RES.0000158967.96231.88)
67. Gourdy P, Mallat Z, Castano C, Garmy-Susini B, Mac Gregor JL, Tedgui A, Arnal JF & Bayard F 2003 The atheroprotective effect of 17 b-estradiol is not altered in P-selectin-or ICAM-1-deficient hypercholesterolemic mice. Atherosclerosis 166 41-48. (doi:10.1016/S0021-9150(02)00322-2)
68. Grasselli A, Nanni S, Colussi C, Aiello A, Benvenuti V, Ragone G, Moretti F, Sacchi A, Bacchetti S, Gaetano C et al. 2008 Estrogen receptor-a and endothelial nitric oxide synthase nuclear complex regulates transcription of human telomerase. Circulation Research 10334-42. (doi:10.1161/CIRCRESAHA.107.169037)
69. Haas E, Bhattacharya I, Brailoiu E, Damjanović M, Brailoiu GC, Gao X, Mueller-Guerre L, Marjon NA, Gut A, Minotti R et al. 2009 Regulatory role of G protein-coupled estrogen receptor for vascular function and obesity. Circulation Research 104 288-291. (doi:10.1161/CIRCRESAHA.108.190892)
70. Hämäläinen M, Nieminen R, Vuorela P, Heinonen M & Moilanen E 2007 Anti-inflammatory effects of flavonoids: genistein, kaempferol, quercetin, and daidzein inhibit STAT-1 and NF-kB activations, whereas flavone, isorhamnetin, naringenin, and pelargonidin inhibit only NF-kB activation along with their inhibitory effect on iNOS expression and NO production in activated macrophages. Mediators of Inflammation ID45673 1-10. (doi:10.1155/2007/45673)
71. Hayashi T, Jayachandran M, Sumi D, Thakur NK, Esaki T, Muto E, Kano H, Asai Y & Iguchi A 2000 Physiological concentration of 17b-estradiol retards the progression of severe atherosclerosis induced by a high-cholesterol diet plus balloon catheter injury: role of NO. Arteriosclerosis, Thrombosis, and Vascular Biology 20 1613-1621. (doi:10.1161/01.ATV.20.6.1613)
72. Hayashi T, Matsui-Hirai H, Miyazaki-Akita A, Fukatsu A, Funami J, Ding QF, Kamalanathan S, Hattori Y, Ignarro LJ & Iguchi A 2006 Endothelial cellular senescence is inhibited by nitric oxide: implications in atherosclerosis associated with menopause and diabetes. PNAS 103 17018-17023. (doi:10.1073/pnas.0607873103)
73. Helisten H, Hockerstedt A, Wähälä K, Tiitinen A, Adlercreutz H, Jauhiainen M & Tikkanen MJ 2001 Accumulation of high-density lipoprotein-derived estradiol-17b fatty acid esters in low-density lipoprotein particles. Journal of Clinical Endocrinology and Metabolism 861 294-1300. (doi:10.1210/jc.86.3.1294)
74. Hockerstedt A, Tikkanen MJ & Jauhiainen M 2002 LCAT facilitates transacylation of 17b-estradiol in the presence of HDL3 subfraction. Journal of Lipid Research 43 392-397.
75. Hockerstedt A, Jauhiainen M & Tikkanen MJ 2004 Lecithin/ cholesterol acyltransferase induces estradiol esterification in high-density lipoprotein increasing its anti-oxidant potential. Journal of Clinical Endocrinology and Metabolism 89 5088-5093. (doi:10.1210/jc.2004-0141)
76. Hodgin JB, Krege JH, Reddick RL, Korach KS, Smithies O & Maeda N 2001 Estrogen receptor a is a major mediator of 17b-estradiol's atheroprotective effects on lesion size in ApoeK/K mice. Journal of Clinical Investigation 107 333-340. (doi:10.1172/JCI11320)
77. Hodgin JB, Knowles JW, Kim HS, Smithies O & Maeda N 2002 Interactions between endothelial nitric oxide synthase and sex hormones in vascular protection in mice. Journal of Clinical Investigation 109 541-548.
78. Holm P, Korsgaard N, Shalmi M, Andersen HL, Hougaard P, Skouby SO & Stender S 1997 Significant reduction of the antiatherogenic effect of estrogen by long-term inhibition of nitric oxide synthesis in cholesterol-clamped rabbits. Journal of Clinical Investigation 100 821-828. (doi:10.1172/JCI119597)
79. Hong HJ, Liu JC, Chan P, Juan SH, Loh SH, Lin JG & Cheng TH 2004 17b-Estradiol downregulates angiotensin-II-induced endothelin-1 gene expression in rat aortic smooth muscle cells. Journal of Biomedical Sciences 11 27-36.
80. Hsieh YC, Frink M, Thobe BM, Hsu JT, Choudhry MA, Schwacha MG, Bland KI & Chaudry IH 2007 17b-Estradiol downregulates Kupffer cell TLR4-dependent p38 MAPK pathway and normalizes inflammatory cytokine production following trauma-hemorrhage. Molecular Immunology 44 2165-2172. (doi:10.1016/j.molimm.2006.11.019)
81. Hulley S, Grady D, Bush T, Furberg C, Herrington D, Riggs B & Vittinghoff E 1998 Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/Progestin Replacement Study (HERS) Research Group. Journal of the American Medical Association 280 605-613. (doi:10.1001/jama.280.7.605)
82. Hwang KC, Lee KH & Jang Y 2002 Inhibition of MEK1,2/ERK mitogenic pathway by estrogen with antiproliferative properties in rat aortic smooth muscle cells. Journal of Steroid Biochemistry and Molecular Biology 80 85-90. (doi:10.1016/S0960-0760(01)00169-8)
83. Javeshghani D, Sairam MR, Neves MF, Schiffrin EL & Touyz RM 2006 Angiotensin II induces vascular dysfunction without exacerbating blood pressure elevation in a mouse model of menopauseassociated hypertension. Journal of Hypertension 24 1365-1373. (doi:10.1097/01.hjh.0000234117.25401.f8)
84. Javeshghani D, Sairam MR, Schiffrin EL & Touyz RM 2007 Increased blood pressure, vascular inflammation, and endothelial dysfunction in androgen-deficient follitropin receptor knockout male mice. Journal of the American Society of Hypertension 1 353-361. (doi:10.1016/j.jash.2007.06.003)
85. Jiang P, Xu J, Zheng S, Huang J, Xiang Q, Fu X & Wang T 2010 17b-Estradiol down-regulates lipopolysaccharide-induced MCP-1 production and cell migration in vascular smooth muscle cells. Journal of Molecular Endocrinology 45 87-97. (doi:10.1677/JME-09-0166)
86. Jun SS, Chen Z, Pace MC & Shaul PW 1998 Estrogen upregulates cyclooxygenase-1 gene expression in ovine fetal pulmonary artery endothelium. Journal of Clinical Investigation 102 176-183. (doi:10.1172/JCI2034)
87. Kappert K, Caglayan E, Huntgeburth M, Bäumer AT, Sparwel J, Uebel M & Rosenkranz S 2006 17b-Estradiol attenuates PDGF signaling in vascular smooth muscle cells at the postreceptor level. American Journal of Physiology. Heart and Circulatory Physiology 290 H538-H546. (doi:10.1152/ajpheart.00240.2005)
88. Kawagoe J, Ohmichi M, Tsutsumi S, Ohta T, Takahashi K & Kurachi H 2007 Mechanism of the divergent effects of estrogen on the cell proliferation of human umbilical endothelial versus aortic smooth muscle cells. Endocrinology 148 6092-6099. (doi:10.1210/en.2007-0188)
89. Kawasaki T, Choudhry MA, Suzuki T, Schwacha MG, Bland KI & Chaudry IH 2008 17b-Estradiol's salutary effects on splenic dendritic cell functions following trauma-hemorrhage are mediated via estrogen receptor-a. Molecular Immunology 45 376-385. (doi:10.1016/j.molimm.2007.06.148)
90. Kolodgie FD, Jacob A, Wilson PS, Carlson GC, Farb A, Verma A & Virmani R 1996 Estradiol attenuates directed migration of vascular smooth muscle cells in vitro. American Journal of Pathology 148 969-976.
91. Krom YD, Pires NM, Jukema JW, de Vries MR, Frants RR, Havekes LM, van Dijk KW & Quax PH 2007 Inhibition of neointima formation by local delivery of estrogen receptor a and b specific agonists. Cardiovascular Research 73 217-226. (doi:10.1016/j.cardiores.2006.10.024)
92. Kurokawa A, Azuma K, Mita T, Toyofuku Y, Fujitani Y, Hirose T, Iwabuchi K, Ogawa H, Takeda S, Kawamori R et al. 2007 2-Methoxyestradiol reduces monocyte adhesion to aortic endothelial cells. Endocrine Journal 54 1027-1031. (doi:10.1507/endocrj.K07E-034)
93. Lea CK, Sarma U & Flanagan AM 1999 Macrophage colony stimulating-factor transcripts are differentially regulated in rat bone-marrow by gender hormones. Endocrinology 140 273-279. (doi:10.1210/en.140.1.273)
94. Lee SA, Park SH & Kim BC 2008 Raloxifene, a selective estrogen receptor modulator, inhibits lipopolysaccharide-induced nitric oxide production by inhibiting the phosphatidylinositol 3-kinase/Akt/nuclear factor-kappa B pathway in RAW264.7 macrophage cells. Molecular Cells 26 48-52.
95. Lerner DJ & Kannel WB 1986 Patterns of coronary heart disease morbidity and mortality in the sexes: a 26-year follow-up of the Framingham population. American Heart Journal 111 383-390. (doi:10.1016/0002-8703(86)90155-9)
96. Ley K, Miller YI & Hedrick CC 2011 Monocyte and macrophage dynamics during atherogenesis. Arteriosclerosis, Thrombosis, and Vascular Biology 31 1506-1516. (doi:10.1161/ATVBAHA.110.221127)
97. Li X, Xu Y, Ma L, Sun L, Fu G & Hou Y 2009 17b-Estradiol enhances the response of plasmacytoid dendritic cell to CpG. PLoS ONE 4 e8412. (doi:10.1371/journal.pone.0008412)
98. Lindner V, Kim SK, Karas RH, Kuiper GG, Gustafsson JA & Mendelsohn ME 1998 Increased expression of estrogen receptor-b mRNA in male blood vessels after vascular injury. Circulation Research 83224-229.
99. Ling S, Little PJ, Williams MR, Dai A, Hashimura K, Liu JP, Komesaroff PA & Sudhir K 2002 High glucose abolishes the antiproliferative effect of 17b-estradiol in human vascular smooth muscle cells. American Journal of Physiology. Endocrinology and Metabolism 282 E746-E751.
100. Ling S, Zhou L, Li H, Dai A, Liu JP, Komesaroff PA & Sudhir K 2006 Effects of 17b-estradiol on growth and apoptosis in human vascular endothelial cells: influence of mechanical strain and tumor necrosis factor-a. Steroids 71 799-808. (doi:10.1016/j.steroids.2006.05.010)
101. Liu WL, Guo X & Guo ZG 2002 Estrogen prevents bovine aortic endothelial cells from TNF-a-induced apoptosis via opposing effects on p38 and p44/42 CCDPK. Acta Pharmacologica Sinica 23 213-218.
102. 0 -cyclic adenosine monophosphate signaling pathway in vascular endothelial cells and protects endothelial barrier function. Endocrinology 146 1312-1320. (doi:10.1210/en.2004-1221)
103. Lou H, Kodama T, Zhao YJ, Maurice P, Wang YN, Katz N & Foegh ML 1996 Inhibition of transplant coronary arteriosclerosis in rabbits by chronic estradiol treatment is associated with abolition of MHC class II antigen expression. Circulation 94 3355-3361.
104. Lu A, Frink M, Choudhry MA, Schwacha MG, Hubbard WJ, Rue LW III, Bland KI & Chaudry IH 2006 Mitochondria play an important role in 17b-estradiol attenuation of H(2)O(2)-induced rat endothelial cell apoptosis. American Journal of Physiology. Endocrinology and Metabolism 292 E585-E593. (doi:10.1152/ajpendo.00413.2006)
105. Maffei L, Murata Y, Rochira V, Tubert G, Aranda C, Vazquez M, Clyne CD, Davis S, Simpson ER & Carani C 2004 Dysmetabolic syndrome in a man with a novel mutation of the aromatase gene: effects of testosterone, alendronate, and estradiol treatment. Journal of Clinical Endocrinology and Metabolism 89 61-70. (doi:10.1210/jc.2003-030313)
106. Maggiolini M & Picard D 2010 The unfolding stories of GPR30, a new membrane-bound estrogen receptor. Journal of Endocrinology 204 105-114. (doi:10.1677/JOE-09-0242)
107. Martin-McNulty B, Tham DM, da Cunha V, Ho JJ, Wilson DW, Rutledge JC, Deng GG, Vergona R, Sullivan ME & Wang YX 2003 17b-Estradiol attenuates development of angiotensin II-induced aortic abdominal aneurysm in apolipoprotein E-deficient mice. Arteriosclerosis, Thrombosis, and Vascular Biology 23 1627-1632.(doi:10.1161/01.ATV.0000085842.20866.6A)
108. Mayer LP, Dyer CA, Eastgard RL, Hoyer PB & Banka CL 2005 Atherosclerotic lesion development in a novel ovary-intact mouse model of perimenopause. Arteriosclerosis, Thrombosis, and Vascular Biology 25 1910-1916. (doi:10.1161/01.ATV.0000175767.46520.6a)
109. McCrohon JA, Nakhla S, Jessup W, Stanley KK & Celermajer DS 1999 Estrogen and progesterone reduce lipid accumulation in human monocyte-derived macrophages: a sex-specific effect. Circulation 100 2319-2325.
110. Mikkola T, Turunen P, Avela K, Orpana A, Viinikka L & Ylikorkala O 1995 17b-Estradiol stimulates prostacyclin, but not endothelin-1, production in human vascular endothelial cells. Journal of Clinical Endocrinology and Metabolism 80 1832-1836. (doi:10.1210/jc.80.6. 1832)
111. Mikkola T, Ranta V, Orpana A, Ylikorkala O & Viinikka L 1996 Effect of physiological concentrations of estradiol on PGI2 and NO in endothelial cells. Maturitas 25 141-147. (doi:10.1016/0378-5122(96)01057-2)
112. Montagna P, Brizzolara R, Soldano S, Pizzorni C, Sulli A & Cutolo M 2009 Sex hormones and leflunomide treatment of human macrophage cultures: effects on apoptosis. International Journal of Clinical and Experimental Medicine 2 221-232.
113. Moore KJ & Tabas I 2011 Macrophages in the pathogenesis of atherosclerosis. Cell 145 341-355. (doi:10.1016/j.cell.2011.04.005)
114. Mor G, Sapi E, Abrahams VM, Rutherford T, Song J, Hao XY, Muzaffar S & Kohen F 2003 Interaction of the estrogen receptors with the Fas ligand promoter in human monocytes. Journal of Immunology 170 114-122.
115. Mori M, Tsukahara F, Yoshioka T, Irie K & Ohta H 2004 Suppression by 17b-estradiol of monocyte adhesion to vascular endothelial cells is mediated by estrogen receptors. Life Sciences 75 599-609. (doi:10.1016/S0024-3205(04)00290-5)
116. Mori-Abe A, Tsutsumi S, Takahashi K, Toya M, Yoshida M, Du B, Kawagoe J, Nakahara K, Takahashi T, Ohmichi M et al. 2003 Estrogen and raloxifene induce apoptosis by activating p38 mitogen-activated protein kinase cascade in synthetic vascular smooth muscle cells. Journal of Endocrinology 178 417-426.(doi:10.1677/joe.0.1780417)
117. Mukherjee TK, Dinh H, Chaudhuri G & Nathan L 2002 Testosterone attenuates expression of vascular cell adhesion molecule-1 by conversion to estradiol by aromatase in endothelial cells: implications in atherosclerosis. PNAS 99 4055-4060. (doi:10.1073/pnas.052703199)
118. Mukherjee TK, Nathan L, Dinh H, Reddy ST & Chaudhuri G 2003 17-Epiestriol, an estrogen metabolite, is more potent than estradiol in inhibiting vascular cell adhesion molecule 1 (VCAM-1) mRNA expression. Journal of Biological Chemistry 278 11746-11752.(doi:10.1074/jbc.M207800200)
119. Muller M, van den Beld AW, Bots ML, Grobbee DE, Lamberts SW & van der Schouw YT 2004 Endogenous sex hormones and progression of carotid atherosclerosis in elderly men. Circulation 109 2074-2079. (doi:10.1161/01.CIR.0000125854.51637.06)
120. Murphy AJ, Guyre PM & Pioli PA 2010 Estradiol suppresses NF-kappa B activation through coordinated regulation of let-7a and miR-125b in primary human macrophages. Journal of Immunology 184 5029-5037. (doi:10.4049/jimmunol.0903463)
121. Nakamura T, Imai Y, Matsumoto T, Sato S, Takeuchi K, Igarashi K, Harada Y, Azuma Y, Krust A, Yamamoto Y et al. 2007 Estrogen prevents bone loss via estrogen receptor a and induction of Fas ligand in osteoclasts. Cell 130 811-823. (doi:10.1016/j.cell.2007.07.025)
122. Napolitano M, Blotta I, Montali A & Bravo E 2001 17b-Estradiol enhances the flux of cholesterol through the cholesteryl ester cycle in human macrophages. Bioscience Reports 21 637-652. (doi:10.1023/ A:1014721026280)
123. Napolitano M, Calcabrini A, Botham KM & Bravo E 2002 Role of estrogen in the regulation of cholesteryl ester synthesis in macrophages: the interaction between native and modified low density lipoprotein and human monocyte-derived macrophages. Clinical Biochemistry 35 597-605. (doi:10.1016/S0009-9120(02)00404-6)
124. Nascimento CA, Kauser K & Rubanyi GM 1999 Effect of 17b-estradiol in hypercholesterolemic rabbits with severe endothelial dysfunction. American Journal of Physiology. Heart and Circulatory Physiology 276 H1788-H1794.
125. Nathan L, Pervin S, Singh R, Rosenfeld M & Chaudhuri G 1999 Estradiol inhibits leukocyte adhesion and transendothelial migration in rabbits in vivo: possible mechanisms for gender differences in atherosclerosis. Circulation Research 85 377-385.
126. Nathan L, Shi W, Dinh H, Mukherjee TK, Wang X, Lusis AJ & Chaudhuri G 2001 Testosterone inhibits early atherogenesis by conversion to estradiol: critical role of aromatase. PNAS 98 3589-3593. (doi:10.1073/pnas.051003698)
127. Nettleship JE, Jones TH, Channer KS & Jones RD 2007 Physiological testosterone replacement therapy attenuates fatty streak formation and improves high-density lipoprotein cholesterol in the Tfm mouse: an effect that is independent of the classic androgen receptor. Circulation 116 2427-2434. (doi:10.1161/CIRCULATIO-NAHA.107.708768)
128. Norata GD, Cattaneo P, Poletti A & Catapano AL 2010 The androgen derivative 5a-androstane-3b,17b-diol inhibits tumor necrosis factor a and lipopolysaccharide induced inflammatory response in human endothelial cells and in mice aorta. Atherosclerosis 212 100-106. (doi:10.1016/j.atherosclerosis.2010.05.015)
129. Orr AW, Hastings NE, Blackman BR & Wamhoff BR 2010 Complex regulation and function of the inflammatory smooth muscle cell phenotype in atherosclerosis. Journal of Vascular Research 47 168-180. (doi:10.1159/000250095)
130. Oviedo PJ, Sobrino A, Laguna-Fernandez A, Novella S, Tarín JJ, García-Pérez MA, Sanchís J, Cano A & Hermenegildo C 2011 Estradiol induces endothelial cell migration and proliferation through estrogen receptor-enhanced RhoA/ROCK pathway. Molecular and Cellular Endocrinology 335 96-103. (doi:10.1016/j.mce.2010.06.020)
131. Pérez-López FR, Chedraui P, Gilbert JJ & Pérez-Roncero G 2009 Cardiovascular risk in menopausal women and prevalent related co-morbid conditions: facing the post-Women's Health Initiative era. Fertility and Sterility 92 1171-1186. (doi:10.1016/j.fertnstert.2009.06.032)
132. Rauschemberger MB, Sandoval MJ & Massheimer VL 2011 Cellular and molecular actions displayed by estrone on vascular endothelium. Molecular and Cellular Endocrinology 339 136-143. (doi:10.1016/j.mce.2011.04.009)
133. Rayner K, Chen YX, McNulty M, Simard T, Zhao X, Wells DJ, de Belleroche J & O'Brien ER 2008 Extracellular release of the atheroprotective heat shock protein 27 is mediated by estrogen and competitively inhibits acLDL binding to scavenger receptor-A. Circulation Research 103 133-141. (doi:10.1161/CIRCRESAHA.108.172155)
134. Rayner K, Sun J, Chen YX, McNulty M, Simard T, Zhao X, Wells DJ, de Belleroche J & O'Brien ER 2009 Heat shock protein 27 protects against atherogenesis via an estrogen-dependent mechanism: role of selective estrogen receptor b modulation. Arteriosclerosis, Thrombosis, and Vascular Biology 29 1751-1756. (doi:10.1161/ATVBAHA.109.193656)
135. Razmara A, Sunday L, Stirone C, Wang XB, Krause DN, Duckles SP & Procaccio V 2008 Mitochondrial effects of estrogen are mediated by estrogen receptor a in brain endothelial cells. Journal of Pharmacology and Experimental Therapeutics 325 782-790. (doi:10.1124/jpet.107.134072)
136. Register TC & Adams MR 1998 Coronary artery and cultured aortic smooth muscle cells express mRNA for both the classical estrogen receptor and the newly described estrogen receptor b. Journal of Steroid Biochemistry and Molecular Biology 64 187-191. (doi:10.1016/S0960-0760(97)00155-6)
137. Rettew JA, Huet YM & Marriott I 2009 Estrogens augment cell surface TLR4 expression on murine macrophages and regulate sepsis susceptibility in vivo. Endocrinology 150 3877-3884. (doi:10.1210/en.2009-0098)
138. Rettew JA, McCall SH IV & Marriott I 2010 GPR30/GPER-1 mediates rapid decreases in TLR4 expression on murine macrophages. Molecular and Cellular Endocrinology 328 87-92. (doi:10.1016/j.mce.2010.07.017)
139. Ribas V, Drew BG, Le JA, Solymani T, Daraei P, Sitz D, Mohammad L, Henstridge DC, Febbraio M, Hewitt SC et al. 2011 Myeloid-specific estrogen a deficiency impairs metabolic homeostasis and accelerates atherosclerotic lesion development. PNAS 108 16457-16462. (doi:10.1073/pnas.1104533108)
140. Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, Jackson RD, Beresford SA, Howard BV, Johnson KC, Kotchen JM & Ockene J 2002 Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. Journal of the American Medical Association 288 21-33.
141. Rossouw JE, Prentice RL, Manson JE, Wu L, Barad D, Barnabei VM, Ko M, LaCroix AZ, Margolis KL & Stefanick ML 2007 Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause. Journal of the American Medical Association 2971465-1477. (doi:10.1001/jama.297.13.1465)
142. Saintier D, Khanine V, Uzan B, Ea HK, de Vernejoul MC & Cohen-Solal ME 2006 Estradiol inhibits adhesion and promotes apoptosis in murine osteoclasts in vitro. Journal of Steroid Biochemistry and Molecular Biology 99 165-173. (doi:10.1016/j.jsbmb.2006.01.009)
143. Saito S, Foegh ML, Motomura N, Lou H, Kent K & Ramwell PW 1998 Estradiol inhibits allograft-inducible major histocompatibility complex class II antigen expression and transplant arteriosclerosis in the absence of immunosuppression. Transplantation 66 1424-1431. (doi:10.1097/00007890-199812150-00004)
144. Sandoval KE & Witt KA 2011 Age and 17b-estradiol effects on blood- brain barrier tight junction and estrogen receptor proteins in ovariectomized rats. Microvascular Research 81 198-205.(doi:10.1016/j.mvr.2010.12.007)
145. Sarma U, Edwards M, Motoyoshi K & Flanagan AM 1998 Inhibition of bone resorption by 17b-estradiol in human bone marrow cultures. Journal of Cellular Physiology 175 99-108. (doi:10.1002/(SICI)1097-4652(199804)175:1!99::AID-JCP11O3.0.CO;2-J)
146. Seeger H, Mueck AO & Lippert TH 1999 Effect of estradiol metabolites on prostacyclin synthesis in human endothelial cell cultures. Life Sciences 65 167-170. (doi:10.1016/S0024-3205(99)00383-5)
147. Seli E, Selam B, Mor G, Kayisli UA, Pehlivan T & Arici A 2001 Estradiol regulates monocyte chemotactic protein-1 in human coronary artery smooth muscle cells: a mechanism for its antiatherogenic effect. Menopause 8 296-301. doi:10.1097/00042192-200107000-00013)
148. Seli E, Guzeloglu-Kayisli O, Kayisli UA, Kizilay G & Arici A 2007 Estrogen increases apoptosis in the arterial wall in a murine atherosclerosis model. Fertility and Sterility 88 1190-1196. (doi:10.1016/j.fertnstert.2007.01.132)
149. Sengupta K, Banerjee S, Saxena NK & Banerjee SK 2004 Thombospondin-1 disrupts estrogen-induced endothelial cell proliferation and migration and its expression is suppressed by estradiol. Molecular Cancer Research 2 150-158.
150. Sherman TS, Chambliss KL, Gibson LL, Pace MC, Mendelsohn ME, Pfister SL & Shaul PW 2002 Estrogen acutely activates prostacyclin synthesis in ovine fetal pulmonary artery endothelium. American Journal of Respiratory Cell and Molecular Biology 26 610-616.
151. Simoncini T, De Caterina R & Genazzani AR 1999 Selective estrogen receptor modulators: different actions on vascular cell adhesion molecule-1 (VCAM-1) expression in human endothelial cells. Journal of Clinical Endocrinology and Metabolism 84 815-818.(doi:10.1210/jc.84.2.815)
152. Simoncini T, Maffei S, Basta G, Barsacchi G, Genazzani AR, Liao JK & De Caterina R 2000 Estrogens and glucocorticoids inhibit endothelial vascular cell adhesion molecule-1 expression by different transcriptional mechanisms. Circulation Research 87 19-25.
153. Siracusa MC, Overstreet MG, Housseau F, Scott AL & Klein SL 2008 17b-Estradiol alters the activity of conventional and IFN-producing killer dendritic cells. Journal of Immunology 180 1423-1431.
154. Sivritas D, Becher MU, Ebrahimian T, Arfa O, Rapp S, Bohner A, Mueller CF, Umemura T, Wassmann S, Nickenig G et al. 2011 Antiproliferative effect of estrogen in vascular smooth muscle cells is mediated by Kruppel-like factor-4 and manganese superoxide dismutase. Basic Research in Cardiology 106 563-575. (doi:10.1007/s00395-011-0174-z)
155. Sobrino A, Mata M, Laguna-Fernandez A, Novella S, Oviedo PJ, García-Pérez MA, Tarín JJ, Cano A & Hermenegildo C 2009 Estradiol stimulates vasodilatory and metabolic pathways in cultured human endothelial cells. PLoS ONE 4 e8242. (doi:10.1371/journal.pone.0008242)
156. Sobrino A, Oviedo PJ, Novella S, Laguna-Fernandez A, Bueno C, García-Pérez MA, Tarín JJ, Cano A & Hermenegildo C 2010 Estradiol selectively stimulates endothelial prostacyclin production through estrogen receptor-a. Journal of Molecular Endocrinology 44 237-246. (doi:10.1677/JME-09-0112)
157. Spyridopoulos I, Sullivan AB, Kearney M, Isner JM & Losordo DW 1997 Estrogen-receptor-mediated inhibition of human endothelial cell apoptosis. Estradiol as a survival factor. Circulation 95 1505-1514.
158. Sribnick EA, Samantaray S, Das A, Smith J, Matzelle DD, Ray SK & Banik NL 2010 Postinjury estrogen treatment of chronic spinal cord injury improves locomotor function in rats. Journal of Neuroscience Research 88 1738-1750.
159. Straub RH 2007 The complex role of estrogenes in inflammation. Endocrine Reviews 28 521-574. (doi:10.1210/er.2007-0001)
160. Strehlow K, Rotter S, Wassmann S, Adam O, Grohé C, Laufs K, Bohm M & Nickenig G 2003 Modulation of antioxidant enzyme expression and function by estrogen. Circulation Research 93170-177. (doi:10.1161/01.RES.0000082334.17947.11)
161. Su EJ, Lin ZH, Zeine R, Yin P, Reierstad S, Innes JE & Bulun SE 2009 Estrogen receptor-b mediates cyclooxygenase-2 expression and vascular prostanoid levels in human placental villous endothelial cells. American Journal of Obstetrics and Gynecology 200 427.e1-427.e8. (doi:10.1016/j.ajog.2009.01.025)
162. Subramanian M & Shaha C 2009 Oestrogen modulates human macrophage apoptosis via differential signalling through oestrogen receptor-a and b. Journal of Cellular and Molecular Medicine 13 2317-2329. (doi:10.1111/j.1582-4934.2008.00679.x)
163. Sudoh N, Toba K, Akishita M, Ako J, Hashimoto M, Iijima K, Kim S, Liang YQ, Ohike Y, Watanabe T et al. 2001 Estrogen prevents oxidative stress-induced endothelial cell apoptosis in rats. Circulation 103 724-749.
164. Sulistiyani & St Clair RW 1997 Effect of 17 b-estradiol on metabolism of acetylated low-density lipoprotein by THP-1 macrophages in culture. Arteriosclerosis, Thrombosis, and Vascular Biology 17 1691-1700. (doi:10.1161/01.ATV.17.9.1691)
165. Sumanasekera WK, Sumanasekera GU, Mattingly KA, Dougherty SM, Keynton RS & Klinge CM 2007 Estradiol and dihydrotestosterone regulate endothelial cell barrier function after hypergravity-induced alterations in MAPK activity. American Journal of Physiology. Cellular Physiology 293 C566-C573. (doi:10.1152/ajpcell.00418.2006)
166. Sun J, Ma X, Chen YX, Rayner K, Hibbert B, McNulty M, Dhaliwal B, Simard T, Ramirez D & O'brien E 2011 Attenuation of atherogenesis via the anti-inflammatory effects of the selective estrogen receptor b modulator 8b-VE2. Journal of Cardiovascular Pharmacology 58399-405. (doi:10.1097/FJC.0b013e318226bd16)
167. Suzuki A, Mizuno K, Ino Y, Okada M, Kikkawa F, Mizutani S & Tomoda Y 1996 Effects of 17b-estradiol and progesterone on growth-factor-induced proliferation and migration in human female aortic smooth muscle cells in vitro. Cardiovascular Research 32 516-523.
168. Suzuki T, Shimizu T, Yu HP, Hsieh YC, Choudhry MA, Bland KI & Chaudry IH 2007 Estrogen receptor-a predominantly mediates the salutary effects of 17b-estradiol on splenic macrophages following trauma-hemorrhage. American Journal of Physiology. Cellular Physiology 293 C978-C984. (doi:10.1152/ajpcell.00092.2007)
169. Suzuki T, Yu HP, Hsieh YC, Choudhry MA, Bland KI & Chaudry IH 2008 Estrogen-mediated activation of non-genomic pathway improves macrophages cytokine production following traumahemorrhage. Journal of Cellular Physiology 214 662-672.(doi:10.1002/jcp.21255)
170. Takahashi K, Ohmichi M, Yoshida M, Hisamoto K, Mabuchi S, Arimoto-Ishida E, Mori A, Tsutsumi S, Tasaka K, Murata Y et al. 2003 Both estrogen and raloxifene cause G1 arrest of vascular smooth muscle cells. Journal of Endocrinology 178 319-329. (doi:10.1677/joe.0.1780319)
171. The Coronary Drug Project Research Group 1970 The Coronary Drug Project: initial findings leading to modifications of its research protocol. Journal of the American Medical Association 214 1303-1313. (doi:10.1001/jama.1970.03180070069012)
172. Thongngarm T, Jenkins JK, Ndebele K & McMurray RW 2003 Estrogen and progesterone modulate monocyte cell cycle progression and apoptosis. American Journal of Reproductive Immunology 49 129-138. (doi:10.1034/j.1600-0897.2003.00015.x)
173. 2C homeostasis alteration in human endothelial cells. Vascular Pharmacology 53 230-238. (doi:10.1016/j.vph.2010.09.001)
174. Tse J, Martin-McNaulty B, Halks-Miller M, Kauser K, DelVecchio V, Vergona R, Sullivan ME & Rubanyi GM 1999 Accelerated atherosclerosis and premature calcified cartilaginous metaplasia in the aorta of diabetic male Apo E knockout mice can be prevented by chronic treatment with 17b-estradiol. Atherosclerosis 144 303-313. (doi:10.1016/S0021-9150(98)00325-6)
175. Tsuda M, Iwai M, Li JM, Li HS, Min LJ, Ide A, Okumura M, Suzuki J, Mogi M, Suzuki H et al. 2005 Inhibitory effects of AT1 receptor blocker, olmesartan, and estrogen on atherosclerosis via antioxidative stress. Hypertension 45 545-551. (doi:10.1161/01.HYP.0000157409.88971.fc)
176. Umetani M & Shaul PW 2011 27-Hydroxycholesterol: the first identified endogenous SERM. Trends in Endocrinology and Metabolism 22 130-135. (doi:10.1016/j.tem.2011.01.003)
177. Vegeto E, Ghisletti S, Meda C, Etteri S, Belcredito S & Maggi A 2004 Regulation of the lipopolysaccharide signal transduction pathway by 17b-estradiol in macrophage cells. Journal of Steroid Biochemistry and Molecular Biology 91 59-66. (doi:10.1016/j.jsbmb.2004.02.004)
178. Villablanca A, Lubahn D, Shelby L, Lloyd K & Barthold S 2004 Susceptibility to early atherosclerosis in male mice is mediated by estrogen receptor a. Arteriosclerosis, Thrombosis, and Vascular Biology 24 1055-1061. (doi:10.1161/01.ATV.0000130467.65290.d4)
179. Villablanca AC, Tenwolde A, Lee M, Huck M, Mumenthaler S & Rutledge JC 2009 17b-Estradiol prevents early-stage atherosclerosis in estrogen receptor-a deficient female mice. Journal of Cardiovascular Translational Research 2 289-299. (doi:10.1007/s12265-009-9103-z)
180. Wagner AH, Schroeter MR & Hecker M 2001 17b-Estradiol inhibition of NADPH oxidase expression in human endothelial cells. FASEB Journal 15 2121-2130. (doi:10.1096/fj.01-0123com)
181. Wang TH, Xiang QL, Chen JW, Pan H & Cui YH 2007 Raloxifene plus 17b-estradiol inhibits proliferation of primary cultured vascular smooth muscle cells and human mammary endothelial cells via the janus kinase/signal transducer and activator of transcription3 cascade. European Journal of Pharmacology 561 7-13. (doi:10.1016/j.ejphar.2007.01.026)
182. Wang J, Zhang R, Xu Y, Zhou H, Wang B & Li S 2008 Genistein inhibits the development of atherosclerosis via inhibiting NF-kappaB and VCAM-1 expression in LDLR knockout mice. Canadian Journal of Physiology and Pharmacology 86 777-7784. (doi:10.1139/Y08-085)
183. Wassmann K, Wassmann S & Nickenig G 2005 Progesterone antagonizes the vasoprotective effect of estrogen on antioxidant enzyme expression and function. Circulation Research 97 1046-1054. (doi:10.1161/01.RES.0000188212.57180.55)
184. Williams MR, Dawood T, Ling S, Dai A, Lew R, Myles K, Funder JW, Sudhir K & Komesaroff PA 2004 Dehydroepiandrosterone increases endothelial cell proliferation in vitro and improves endothelial function in vivo by mechanisms independent of androgen and estrogen receptors. Journal of Clinical Endocrinology and Metabolism 89 4708-47015. (doi:10.1210/jc.2003-031560)
185. Wilson ME, Sengoku T & Allred KF 2008 Estrogen prevents cholesteryl ester accumulation in macrophages induced by the HIV protease inhibitor ritonavir. Journal of Cellular Biochemistry 103 1598-1606. (doi:10.1002/jcb.21546)
186. Wing LY, Chen YC, Shih YY, Cheng JC, Lin YJ & Jiang MJ 2009 Effects of oral estrogen on aortic ROS-generating and -scavenging enzymes and atherosclerosis in apoE-deficient mice. Experimental Biology and Medicine 234 1037-1046. (doi:10.3181/0811-RM-332)
187. Xing D, Feng W, Miller AP, Weathington NM, Chen YF, Novak L, Blalock JE & Oparil S 2007 Estrogen modulates TNF-a-induced inflammatory responses in rat aortic smooth muscle cells through estrogen receptor-b activation. American Journal of Physiology. Heart and Circulatory Physiology 292 H2607-H2612. (doi:10.1152/ajpheart.01107.2006)
188. Xiu-li W, Wen-jun C, Hui-hua D, Su-ping H & Shi-long F 2009 ERB-041, a selective ERb agonist, inhibits iNOS production in LPS-activated peritoneal macrophages of endometriosis via suppression of NF-kappaB activation. Molecular Immunology 46 2413-2418. (doi:10.1016/j.molimm.2009.04.014)
189. Yang Z, Cheng B, Song J, Wan Y, Wang Q, Cheng B & Chen X 2007 Estrogen accelerates G1 to S phase transition and induces a G2/M phase-predominant apoptosis in synthetic vascular smooth muscle cells. International Journal of Cardiology 118 381-388. (doi:10.1016/j.ijcard.2006.07.049)
190. Yao PM & Tabas I 2000 Free cholesterol loading of macrophages induces apoptosis involving the fas pathway. Journal of Biological Chemistry 275 23807-23813. (doi:10.1074/jbc.M002087200)
191. Ye L, Martin TA, Parr C, Harrison GM, Mansel RE & Jiang WG 2003 Biphasic effects of 17-b-estradiol on expression of occludin and transendothelial resistance and paracellular permeability in human vascular endothelial cells. Journal of Cellular Physiology 196 362-369. (doi:10.1002/jcp.10315)
192. Yoon BK, Oh WJ, Kessel B, Roh CR, Choi D, Lee JH & Kim DK 2001 17b-Estradiol inhibits proliferation of cultured vascular smooth muscle cells induced by lysophosphatidylcholine via a nongenomic antioxidant mechanism. Menopause 8 58-64. (doi:10.1097/00042192-200101000-00010)
193. Yoshitake J, Kato K, Yoshioka D, Sueishi Y, Sawa T, Akaike T & Yoshimura T 2008 Suppression of NO production and 8-nitroguanosine formation by phenol-containing endocrine-disrupting chemicals in LPS-stimulated macrophages: involvement of estrogen receptor-dependent or -independent pathways. Nitric Oxide 18 223-228. (doi:10.1016/j.niox.2008.01.003)
194. Yu J, Eto M, Akishita M, Okabe T & Ouchi Y 2009 A selective estrogen receptor modulator inhibits TNF-a-induced apoptosis by activating ERK1/2 signaling pathway in vascular endothelial cells. Vascular Pharmacology 51 21-28. (doi:10.1016/j.vph.2009.01.003)
195. Yuan Y, Shimizu I, Shen M, Aoyagi E, Takenaka H, Itagaki T, Urata M, Sannomiya K, Kohno N, Tamaki K et al. 2008 Effects of estradiol and progesterone on the proinflammatory cytokine production by mononuclear cells from patients with chronic hepatitis C. World Journal of Gastroenterology 14 2200-2207. (doi:10.3748/wjg.14.2200)
196. Zacharia LC, Gogos JA, Karayiorgou M, Jackson EK, Gillespie DG, Barchiesi F & Dubey RK 2003 Methoxyestradiols mediate the antimitogenic effects of 17b-estradiol. Circulation 108 2974-2978. (doi:10.1161/01.CIR.0000106900.66354.30)
197. Zacharia LC, Piche CA, Fielding RM, Holland KM, Allison SD, Dubey RK & Jackson EK 2004 2-Hydroxyestradiol is a prodrug of 2-methoxyestradiol. Journal of Pharmacology and Experimental Therapeutics 309 1093-1097. (doi:10.1124/jpet.103.062505)
198. Zhang HH, Feng L, Livnat I, Hoh JK, Shim JY, Liao WX & Chen DB 2010 Estradiol-17b stimulates specific receptor and endogenous nitric oxide-dependent dynamic endothelial protein S-nitrosylation: analysis of endothelial nitrosyl-proteome. Endocrinology 151 3874-3887. (doi:10.1210/en.2009-1356)
199. Zhang HH, Feng L, Wang W, Magness RR & Chen DB 2012 Estrogenresponsive nitroso-proteome in uterine artery endothelial cells: role of endothelial nitric oxide synthase and estrogen receptor-b. Journal of Cellular Physiology 227 146-159. (doi:10.1002/jcp.22712)